BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33030191)

  • 1. Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells.
    Yousefi Sadeghloo A; Khorsandi K; Kianmehr Z
    Photochem Photobiol Sci; 2020 Nov; 19(11):1580-1589. PubMed ID: 33030191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 808 nm NIR Laser-Excited Upconversion Nanoplatform for Combinatory Photodynamic and Chemotherapy with Deep Penetration and Acid Bursting Release Performance.
    Zhong Y; Dong Y; Chen T; Yang L; Yao M; Zhi Y; Yang H; Zhang J; Bi W
    ACS Appl Bio Mater; 2021 Mar; 4(3):2639-2653. PubMed ID: 35014380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue and photodynamic therapy for melanomas: Inducing different rates of cell death (necrosis and apoptosis) in B16-F10 melanoma cells according to methylene blue concentration and energy dose.
    Grande MPD; Miyake AM; Nagamine MK; Leite JVP; da Fonseca IIM; Massoco CO; Dagli MLZ
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102635. PubMed ID: 34798348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of the combination therapy on ovarian cancer cells under microfluidic conditions.
    Flont M; Jastrzębska E; Brzózka Z
    Anal Chim Acta; 2020 Mar; 1100():138-148. PubMed ID: 31987134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
    Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
    Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient combined near-infrared-triggered therapy: Phototherapy over chemotherapy in chitosan-reduced graphene oxide-IR820 dye-doxorubicin nanoplatforms.
    Zaharie-Butucel D; Potara M; Suarasan S; Licarete E; Astilean S
    J Colloid Interface Sci; 2019 Sep; 552():218-229. PubMed ID: 31128402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells.
    Dos Santos AF; Terra LF; Wailemann RA; Oliveira TC; Gomes VM; Mineiro MF; Meotti FC; Bruni-Cardoso A; Baptista MS; Labriola L
    BMC Cancer; 2017 Mar; 17(1):194. PubMed ID: 28298203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
    Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
    J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles of methylene blue enhance photodynamic therapy.
    Jesus VPS; Raniero L; Lemes GM; Bhattacharjee TT; Caetano Júnior PC; Castilho ML
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():212-217. PubMed ID: 29928992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes.
    Alkaraki A; Alshaer W; Wehaibi S; Gharaibeh L; Abuarqoub D; Alqudah DA; Al-Azzawi H; Zureigat H; Souleiman M; Awidi A
    Breast Cancer; 2020 Sep; 27(5):989-998. PubMed ID: 32328816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic chemo-photodynamic therapy mediated by light-activated ROS-degradable nanocarriers.
    Chen Y; Gao Y; Li Y; Wang K; Zhu J
    J Mater Chem B; 2019 Jan; 7(3):460-468. PubMed ID: 32254733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
    Khdair A; Handa H; Mao G; Panyam J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclareol is a potent enhancer of doxorubicin: Evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer.
    Borges GSM; Silva JO; Fernandes RS; de Souza ÂM; Cassali GD; Yoshida MI; Leite EA; de Barros ALB; Ferreira LAM
    Life Sci; 2019 Sep; 232():116678. PubMed ID: 31344429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
    Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
    Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graphene oxide-methylene blue nanocomposite in photodynamic therapy of human breast cancer.
    Hosseinzadeh R; Khorsandi K; Hosseinzadeh G
    J Biomol Struct Dyn; 2018 Jul; 36(9):2216-2223. PubMed ID: 28681663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low power blue LED exposure increases effects of doxorubicin on MDA-MB-231 breast cancer cells.
    Teixeira AF; Alves JR; de Souza da Fonseca A; Mencalha AL
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():250-255. PubMed ID: 30063989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
    Gao D; Lo PC
    J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
    Abrahams B; Gerber A; Hiss DC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.